As of Jul 02
| -0.24 / -1.27%|
The 6 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 25.50, with a high estimate of 38.00 and a low estimate of 24.00. The median estimate represents a +37.17% increase from the last price of 18.59.
The current consensus among 8 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.